CREATE Medicines, cofounded by Siddhartha Mukherjee, closed a $122M Series B to advance in‑vivo CAR‑T candidates for cancer and autoimmune disease.

A PLOS ONE study traced a 2020 apartment outbreak to shared bathroom ducts and urges retrofits — exhaust fans and non‑return flaps — to reduce airborne spread.

El Paso Children’s Hospital added a Lumenis UltraPulse CO2 laser and a ZEISS KINEVO 900 S microscope to expand burn, scar and complex-surgery care closer to home. Hospital officials say the upgrades will keep more specialty treatment in the Borderland.

MIT leaders say federal research cuts and falling grad enrollment forced tighter budgets and fewer admissions — a shift President Sally Kornbluth calls "a striking loss."

Humacyte cut roughly 25% of its staff as it trims spending and refocuses commercial efforts for Symvess while preparing for upcoming trial data.

State regulators approved Dana-Farber’s roughly $50.5M proton therapy center at Longwood, a compact ambulatory build aimed at expanding pediatric and adult access.

Google’s Project Suncatcher has moved from research into launch talks, and SpaceX may be a partner; prototypes are slated for early 2027 amid major technical questions.

Cisco raised its fiscal 2026 revenue forecast to $62.8–$63B and announced a restructuring that could cost up to $1B in pre‑tax charges, with local job impacts still unclear.

Goldman Sachs' operations chief says the bank will build a 'digital factory floor' of AI agents to automate back‑office work while saying overall headcount should stay largely unchanged.

Rocket Lab will acquire Motiv Space Systems, bringing the Pasadena team that built Perseverance’s robotic arm into Rocket Lab Robotics.

ACC and Central Texas school districts have launched a healthcare academy that lets ninth-graders earn industry credentials and stack them toward ACC degrees. The program is backed by more than $10 million in grants.

Anthropic is reportedly courting $30–$50B in fresh capital that could value the San Francisco AI firm near $1 trillion as Claude demand strains compute.

A millisecond 'nanochip' used with nerve grafts helped grow blood vessels and speed functional recovery in mice, Ohio State researchers report. The approach is promising but still preclinical.